Table of Contents Feed for the Digital Edition of BioPharm International - July 2007 Contents From the Editor Global News Regulatory Beat China Today Outsourcing Insights Maximizing Process Data From Development to Manufacturing Regulatory Considerations Regarding Quality Aspects of Monoclonal Antibodies The Biovest AutovaxID: Enabling the Promise of Personalized Medicine BioPharm International - July 2007 BioPharm International - July 2007 - (Page 1) BioPharm International - July 2007 - (Page 2) BioPharm International - July 2007 - (Page 3) BioPharm International - July 2007 - Contents (Page 4) BioPharm International - July 2007 - Contents (Page 5) BioPharm International - July 2007 - Contents (Page 6) BioPharm International - July 2007 - Contents (Page 7) BioPharm International - July 2007 - From the Editor (Page 8) BioPharm International - July 2007 - From the Editor (Page 9) BioPharm International - July 2007 - Global News (Page 10) BioPharm International - July 2007 - Global News (Page 11) BioPharm International - July 2007 - Global News (Page 12) BioPharm International - July 2007 - Regulatory Beat (Page 13) BioPharm International - July 2007 - Regulatory Beat (Page 14) BioPharm International - July 2007 - China Today (Page 15) BioPharm International - July 2007 - China Today (Page 16) BioPharm International - July 2007 - China Today (Page 17) BioPharm International - July 2007 - China Today (Page 18) BioPharm International - July 2007 - Outsourcing Insights (Page 19) BioPharm International - July 2007 - Outsourcing Insights (Page 20) BioPharm International - July 2007 - Maximizing Process Data From Development to Manufacturing (Page 21) BioPharm International - July 2007 - Maximizing Process Data From Development to Manufacturing (Page 22) BioPharm International - July 2007 - Maximizing Process Data From Development to Manufacturing (Page 23) BioPharm International - July 2007 - Maximizing Process Data From Development to Manufacturing (Page 24) BioPharm International - July 2007 - Maximizing Process Data From Development to Manufacturing (Page 25) BioPharm International - July 2007 - Regulatory Considerations Regarding Quality Aspects of Monoclonal Antibodies (Page 26) BioPharm International - July 2007 - Regulatory Considerations Regarding Quality Aspects of Monoclonal Antibodies (Page 27) BioPharm International - July 2007 - Regulatory Considerations Regarding Quality Aspects of Monoclonal Antibodies (Page 28) BioPharm International - July 2007 - Regulatory Considerations Regarding Quality Aspects of Monoclonal Antibodies (Page 29) BioPharm International - July 2007 - Regulatory Considerations Regarding Quality Aspects of Monoclonal Antibodies (Page 30) BioPharm International - July 2007 - Regulatory Considerations Regarding Quality Aspects of Monoclonal Antibodies (Page 31) BioPharm International - July 2007 - Regulatory Considerations Regarding Quality Aspects of Monoclonal Antibodies (Page 32) BioPharm International - July 2007 - Regulatory Considerations Regarding Quality Aspects of Monoclonal Antibodies (Page 33) BioPharm International - July 2007 - Regulatory Considerations Regarding Quality Aspects of Monoclonal Antibodies (Page 34) BioPharm International - July 2007 - The Biovest AutovaxID: Enabling the Promise of Personalized Medicine (Page 35) BioPharm International - July 2007 - The Biovest AutovaxID: Enabling the Promise of Personalized Medicine (Page 36) BioPharm International - July 2007 - The Biovest AutovaxID: Enabling the Promise of Personalized Medicine (Page 37) BioPharm International - July 2007 - The Biovest AutovaxID: Enabling the Promise of Personalized Medicine (Page 38) BioPharm International - July 2007 - The Biovest AutovaxID: Enabling the Promise of Personalized Medicine (Page 39)
For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.